19.02.2015
- Three months after acquiring US Botox producer Allergan for $66 billion, Ireland-based drugmaker Actavis has announced it will adopt Allergan as the name of the merged corporate...
24.11.2014
- Valeant Pharmaceuticals International has cut its stake in US drugmaker Allergan to 0.1%, making the sale three days after Actavis trumped its offer for the Botox maker.In a...
19.11.2014
- After a seven month-long power struggle, US Botox manufacturer Allergan has agreed to be bought by Ireland-based drugmaker Actavis for $66 billion or $219 per share. This is more...
04.11.2014
- Botox maker Allergan, which is fighting a hostile takeover bid by Valeant Pharmaceutical, is said to have been approached about a potential transaction by another party. The news...
24.10.2014
- Boehringer Ingelheim is not bidding for Belgian over-the-counter drugmaker Omega Pharma, a company spokesperson has confirmed. News agencies reported earlier this week that the...
29.04.2014
- Generics producer Actavis has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Israel's Teva to sell a generic version of Pfizer's...
07.04.2014
- Swedish generic drugmaker Meda has rejected a takeover approach by U.S. rival Mylan to create a combined company worth around $24 billion. Reports said Mylan was exploring a bid at...
21.02.2014
- Dublin, Ireland-based generic drugmaker Actavis is acquiring specialty pharmaceuticals company Forest Laboratories of New York in a cash and stock deal valued at about $25 billion...
